Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, November 2000, p. 960-963, Vol. 7, No. 6
Retrovirology Research Laboratory, Pacific
Biomedical Research Center, University of Hawaii at Manoa,
Honolulu, Hawaii 96822,1 and University
of Hawaii Department of Pediatrics, Kapiolani Medical Center for
Women and Children, Honolulu, Hawaii 968262
Received 12 June 2000/Returned for modification 24 August
2000/Accepted 18 September 2000
The role of TT virus (TTV) as a human pathogen is unclear, as is
the mode of TTV transmission. To determine the prevalence of TTV
infection and the possible fecal-oral route of transmission, we
analyzed fecal specimens from 67 healthy, nontransfused children for
TTV DNA sequences by heminested PCR, using the NG and T primer sets.
The overall prevalence of TTV fecal excretion was 22.4% (15 of 67),
with the T primer set (19.4%) being more sensitive than the NG primer
set (10.4%). TTV prevalence based on gender or ethnicity showed no
significant differences. None of seven children in the 0- to 6-month
age group had detectable TTV in feces. Of three sets of siblings, two
unrelated sets of twins, ages 33 and 37 months, were negative for fecal
TTV DNA, while the third set of siblings, ages 99 and 35 months, was
positive. The absence of TTV in the feces of children younger than 6 months and the high prevalence (40%) in children 7 to 12 months of age is consistent with age-specific acquisition of TTV infection by the
nonparenteral route. TTV genotypes 1, 3, 4, and 5 were represented in
our study population. TTV-positive siblings had TTV genotypes 1 and 4, suggesting unrelated environmental sources of TTV infection. This
observation suggests a possible time frame for TTV acquisition in
children which coincides with increased interaction with their environment and increased susceptibility to infectious agents.
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Fecal Excretion of a Novel Human Circovirus, TT
Virus, in Healthy Children
*
Corresponding author. Mailing address: Retrovirology
Research Laboratory, Leahi Hospital, Atherton Building, 2nd Floor, 3675 Kilauea Avenue, Honolulu, HI 96816. Phone: (808) 732-7702. Fax: (808)
735-3682. E-mail: nerurkar{at}hawaii.edu.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |